Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire therapeutic landscape and the whole drug discovery pipeline.

Tcs: Ashok Krish told PTI in an interview true high-value implementations are happening in companies that see AI not as an IT ...

Medicine has always demanded speed, accuracy, and compassion, but physicians in 2025 face greater challenges than ever before ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

While nations like South Africa and Egypt are making early strides in quantum research, Ghana has a unique opportunity to ...

Carterra Inc, a provider of innovative technologies, is partnering with ImmunoPrecise Antibodies (IPA), ACROBiosystems, and ...

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...